News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,843 Results
Type
Article (13822)
Company Profile (101)
Press Release (251920)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88080)
Career Advice (466)
Deals (15347)
Drug Delivery (67)
Drug Development (36613)
Employer Resources (49)
FDA (6297)
Job Trends (6202)
News (150273)
Policy (14045)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (441)
Accelerated approval (2)
Adcomms (6)
Allergies (33)
Alliances (23239)
ALS (36)
Alzheimer's disease (393)
Antibody-drug conjugate (ADC) (41)
Approvals (6333)
Artificial intelligence (107)
Autoimmune disease (9)
Automation (4)
Bankruptcy (149)
Best Places to Work (4371)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (40)
Bladder cancer (20)
Brain cancer (16)
Breast cancer (78)
Cancer (611)
Cardiovascular disease (72)
Career advice (409)
Career pathing (12)
CAR-T (22)
Cell therapy (88)
Cervical cancer (4)
Clinical research (30935)
Collaboration (344)
Compensation (155)
Complete response letters (17)
COVID-19 (757)
CRISPR (20)
C-suite (124)
Cystic fibrosis (37)
Data (639)
Denatured (15)
Depression (9)
Diabetes (81)
Diagnostics (1319)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (61)
Drug pricing (65)
Drug shortages (12)
Duchenne muscular dystrophy (36)
Earnings (32148)
Editorial (12)
Employer branding (4)
Employer resources (43)
Events (37528)
Executive appointments (392)
FDA (6718)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (215)
Gene editing (38)
Generative AI (9)
Gene therapy (100)
GLP-1 (349)
Government (1299)
Grass and pollen (3)
Guidances (16)
Healthcare (3567)
Huntington's disease (4)
IgA nephropathy (11)
Immunology and inflammation (34)
Indications (14)
Infectious disease (792)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (47)
Interviews (60)
IPO (5879)
IRA (29)
Job creations (2051)
Job search strategy (373)
Kidney cancer (6)
Labor market (12)
Layoffs (180)
Leadership (3)
Legal (3433)
Liver cancer (19)
Lung cancer (82)
Lymphoma (55)
Machine learning (1)
Management (16)
Manufacturing (158)
MASH (32)
Medical device (1277)
Medtech (1279)
Mergers & acquisitions (9676)
Metabolic disorders (262)
Multiple sclerosis (21)
NASH (14)
Neurodegenerative disease (24)
Neuropsychiatric disorders (8)
Neuroscience (578)
NextGen: Class of 2025 (1586)
Non-profit (595)
Northern California (712)
Now hiring (8)
Obesity (150)
Opinion (119)
Ovarian cancer (21)
Pain (51)
Pancreatic cancer (13)
Parkinson's disease (46)
Partnered (7)
Patents (117)
Patient recruitment (29)
Peanut (10)
People (28962)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8050)
Phase II (13091)
Phase III (11744)
Pipeline (445)
Policy (71)
Postmarket research (1401)
Preclinical (3219)
Press Release (25)
Prostate cancer (46)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (168)
Real estate (2638)
Recruiting (17)
Regulatory (10122)
Reports (14)
Research institute (565)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (37)
Series A (37)
Series B (13)
Service/supplier (3)
Sickle cell disease (32)
Southern California (724)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1629)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (26)
The Weekly (30)
United States (7252)
Vaccines (153)
Venture capitalists (14)
Weight loss (100)
Women's health (8)
Worklife (3)
Date
Today (68)
Last 7 days (192)
Last 30 days (898)
Last 365 days (11806)
2025 (3617)
2024 (12502)
2023 (14246)
2022 (19560)
2021 (20076)
2020 (19037)
2019 (14891)
2018 (11724)
2017 (13889)
2016 (13130)
2015 (15474)
2014 (12419)
2013 (10593)
2012 (11395)
2011 (11923)
2010 (10890)
Location
Africa (314)
Alabama (13)
Alaska (1)
Arizona (55)
Arkansas (3)
Asia (20132)
Australia (2616)
California (1728)
Canada (910)
China (239)
Colorado (69)
Connecticut (68)
Delaware (56)
Europe (39467)
Florida (328)
Georgia (38)
Idaho (9)
Illinois (197)
India (16)
Indiana (135)
Iowa (1)
Japan (93)
Kansas (57)
Kentucky (12)
Louisiana (1)
Maine (2)
Maryland (258)
Massachusetts (1492)
Michigan (30)
Minnesota (95)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (8)
New Hampshire (6)
New Jersey (768)
New Mexico (7)
New York (513)
North Carolina (395)
North Dakota (2)
Northern California (712)
Ohio (51)
Oklahoma (4)
Oregon (16)
Pennsylvania (444)
Puerto Rico (8)
Rhode Island (10)
South America (503)
South Carolina (2)
Southern California (724)
Tennessee (34)
Texas (233)
Utah (33)
Virginia (75)
Washington D.C. (31)
Washington State (119)
Wisconsin (16)
265,843 Results for "lexicon pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Obesity
Novo’s Obesity Pipeline Keeps Evolving With up to $1B Lexicon Deal
Lexicon’s LX9851 targets ACSL5, a liver enzyme involved in fat metabolism that helps moderate fat accumulation and slow down gastric emptying.
March 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Lexicon Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
April 2, 2025
·
1 min read
Press Releases
Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851
March 31, 2025
·
5 min read
Press Releases
Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025
March 7, 2025
·
1 min read
Adcomms
Lexicon Loses FDA Adcomm Vote on Insulin Adjunct for Patients With Type 1 Diabetes
While an FDA advisory committee saw signals of efficacy for Lexicon Pharmaceuticals’ sotagliflozin, the panel of external experts found that the company did not provide enough data to support its drug application.
November 1, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Lexicon Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
March 4, 2025
·
1 min read
Press Releases
Lexicon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
March 6, 2025
·
15 min read
Lone Star Bio
Lexicon Pharmaceuticals to Host 2024 Investor Day
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that senior company executives will be joined by leading physicians at the Lexicon 2024 Investor Day on April 22, 2024.
April 18, 2024
·
3 min read
Lone Star Bio
Lexicon Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2024
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the Jefferies Global Healthcare Conference.
May 29, 2024
·
2 min read
Lone Star Bio
Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024
Lexicon Pharmaceuticals, Inc. announced its participation in the Bank of America Securities Healthcare Conference 2024. Jeff Wade, Lexicon’s president and chief financial officer, will make a company presentation on Tuesday, May 14, 2024, at 8:00 am PDT.
May 9, 2024
·
2 min read
1 of 26,585
Next
